Source:http://linkedlifedata.com/resource/pubmed/id/20811689
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-9-2
|
pubmed:abstractText |
Telomere stability is believed to be related to aging and tumorigenesis. Besides telomerase, telomere length is also regulated by several telomere-specific binding proteins. Tankyrase 1, a telomeric poly(ADP-ribose) polymerase (PARP), elongates telomere length by inhibiting TRF1 binding to telomeres. In order to study the synergistic action of tankyrase 1 and telomerase in the maintenance of telomere length in mammalian cells, we constructed anti-sense tankyrase 1 (aTNKS) eukaryotic expression vectors and then transfected them into the SGC-7901 human gastric cancer cell line, as well as SGC-7901 cells that had been transfected with antisense hTR (7901-ahTR) and antisense hTERT (7901-ahTERT) with DOTAP liposomes. The activity of telomerase, telomere length and telomerase-associated protein activities were measure by TRAP-ELISA, Southern blot and western blot analysis, respectively, in aTNKS transfected and untransfected cells. The results demonstrated that telomere length was significantly shorter in cells with concomitant tankyrase 1 and telomerase inhibition than by either tankyrase 1 or telomerase inhibition alone, in SGC-7901 cells. We also found that aTNKS had no effect on telomerase activity. These results reveal that inhibition of tankyrase 1 could shorten telomere length and play a synergistic role with telomerase inhibitors in telomere length shortening in the SGC-7901 gastric cancer cell line. Co-inhibition of tankyrase 1 and telomerase activity may be a rational strategy for telomere-directed gastric cancer therapeutics.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1791-2431
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1059-65
|
pubmed:meshHeading |
pubmed-meshheading:20811689-Blotting, Southern,
pubmed-meshheading:20811689-Blotting, Western,
pubmed-meshheading:20811689-Cell Line, Tumor,
pubmed-meshheading:20811689-Enzyme Inhibitors,
pubmed-meshheading:20811689-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20811689-Humans,
pubmed-meshheading:20811689-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20811689-Stomach Neoplasms,
pubmed-meshheading:20811689-Tankyrases,
pubmed-meshheading:20811689-Telomerase,
pubmed-meshheading:20811689-Telomere,
pubmed-meshheading:20811689-Transfection
|
pubmed:year |
2010
|
pubmed:articleTitle |
Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors.
|
pubmed:affiliation |
Institute of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing 400038, P.R. China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|